Paper9689101
An immune cell-selective interleukin 4 agonist.
Shanafelt AB and 6 others. Proc Natl Acad Sci U S A, 1998. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. An immune cell-selective interleukin 4 agonist. Papers, record 9689101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9689101
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-4 | Major topic |
| B-Lymphocytes | |
| Binding, Competitive | |
| Cells, Cultured | |
| Endothelium, Vascular | |
| Humans | |
| Receptors, Interleukin-4 | |
| T-Lymphocytes |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8616884 | Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. | Cell | 1996 | https://conductscience.org/library/papers/8616884 | PubMed |
| 2 | 8616883 | Insulin-dependent diabetes mellitus. | Cell | 1996 | https://conductscience.org/library/papers/8616883 | PubMed |
| 3 | 8698849 | IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8698849 | PubMed |
| 4 | 8893001 | Functional diversity of helper T lymphocytes. | Nature | 1996 | https://conductscience.org/library/papers/8893001 | PubMed |
| 5 | 8910586 | cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8910586 | PubMed |
| 6 | 8991384 | IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. | Immunol Today | 1996 | https://conductscience.org/library/papers/8991384 | PubMed |
| 7 | 8982776 | Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. | Int Immunol | 1996 | https://conductscience.org/library/papers/8982776 | PubMed |
| 8 | 9034722 | Functions of IL-4 and control of its expression. | Crit Rev Immunol | 1997 | https://conductscience.org/library/papers/9034722 | PubMed |
| 9 | 9050834 | A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9050834 | PubMed |
| 10 | 9199969 | IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. | Int Immunol | 1997 | https://conductscience.org/library/papers/9199969 | PubMed |
| 11 | 9299458 | Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells. | Biochem Biophys Res Commun | 1997 | https://conductscience.org/library/papers/9299458 | PubMed |
| 12 | 6304457 | LIGAND: a computerized analysis of ligand binding data. | Methods Enzymol | 1983 | https://conductscience.org/library/papers/6304457 | PubMed |
| 13 | 2419430 | Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. | J Immunol | 1986 | https://conductscience.org/library/papers/2419430 | PubMed |
| 14 | 3323813 | Rapid and efficient site-specific mutagenesis without phenotypic selection. | Methods Enzymol | 1987 | https://conductscience.org/library/papers/3323813 | PubMed |
| 15 | 1702807 | Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. | J Immunol | 1991 | https://conductscience.org/library/papers/1702807 | PubMed |
| 16 | 1542854 | Acute gastric mucosal injury associated with the systemic administration of interleukin-4. | Surgery | 1992 | https://conductscience.org/library/papers/1542854 | PubMed |
| 17 | 1377515 | Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells. | Cytokine | 1992 | https://conductscience.org/library/papers/1377515 | PubMed |
| 18 | 1387082 | Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. | EMBO J | 1992 | https://conductscience.org/library/papers/1387082 | PubMed |
| 19 | 1383333 | Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. | J Immunol | 1992 | https://conductscience.org/library/papers/1383333 | PubMed |
| 20 | 1403061 | Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1403061 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37483220 | Design of Glycoengineered IL-4 Antagonists Employing Chemical and Biosynthetic Glycosylation. | ACS Omega | 2023 | https://conductscience.org/library/papers/37483220 | PubMed |
| 30341437 | Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. | Nat Rev Rheumatol | 2019 | https://conductscience.org/library/papers/30341437 | PubMed |
| 30319612 | Mapping Determinants of Cytokine Signaling via Protein Engineering. | Front Immunol | 2018 | https://conductscience.org/library/papers/30319612 | PubMed |
| 25493332 | Insights into cytokine-receptor interactions from cytokine engineering. | Annu Rev Immunol | 2015 | https://conductscience.org/library/papers/25493332 | PubMed |
| 23183579 | Immunology: Evolving superkines for selectivity. | Nat Chem Biol | 2012 | https://conductscience.org/library/papers/23183579 | PubMed |
| 20562098 | Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20562098 | PubMed |
| 16640778 | A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor. | BMC Biol | 2006 | https://conductscience.org/library/papers/16640778 | PubMed |
| 16566861 | Cytokine and anti-cytokine therapy for asthma. | Curr Allergy Asthma Rep | 2006 | https://conductscience.org/library/papers/16566861 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL13RA1 | 3597 | PubTator's text mining | https://conductscience.org/library/genes/3597 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| IL4R | 3566 | PubTator's text mining | https://conductscience.org/library/genes/3566 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9689101
GET https://conductscience.org/api/papers/v1/9689101/references?page=2